The role of entacapone in the management of Parkinson's disease

Citation
Dj. Brooks et al., The role of entacapone in the management of Parkinson's disease, HOSP MED, 61(4), 2000, pp. 267-271
Citations number
14
Categorie Soggetti
General & Internal Medicine
Journal title
HOSPITAL MEDICINE
ISSN journal
14623935 → ACNP
Volume
61
Issue
4
Year of publication
2000
Pages
267 - 271
Database
ISI
SICI code
1462-3935(200004)61:4<267:TROEIT>2.0.ZU;2-X
Abstract
Catechol-O-methyltransferase (COMT) inhibition is an important advance in t he treatment of parkinson's disease. This consensus statement provides guid elines for the optimal use of the only currently available COMT inhibitor, entacapone (Comtess(R) Orion Pharma (UK) Ltd, Newbury, Berkshire).